Four distinct physiological mimetics may extend life through four independent functions
Butyrate support of colon cells, bacterial suppression by isoallolithocholic acid, muscle adaptation and epithelial repair may each contribute to longer life. The proposed separation of the microbial effects would fail if selectively disabling either function also removed the other's life benefit
Stage of verification
- Hypothesis published2026-10-05
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Metabolism and energy
Colonocyte metabolism
Metabolic activity in colonocytes
Where this hypothesis actsMature colonocytes, with other baseline physiological functions preserved
Hypotheses on this target 1
Inhibition
Activation
Function preservation
Supplementation1
Feedback restoration
Direct measurement

What is proposed
Supplementation
Support colonocyte metabolism
With whatSmall molecule
HowProvide butyrate, whose proposed contribution depends on its use by mature colonocytes
Possible result
Possible independent increase in mean remaining lifespan
From the recordБутират поддерживает обмен зрелых колоноцитов

Microbial community
Gut microbiota
The community of microorganisms living in the gut
Where this hypothesis actsSusceptible intestinal bacteria, with other baseline physiological functions preserved
Hypotheses on this target 3
Population balance1
Community restoration
Colonisation1
What is proposed
Suppress susceptible gut bacteria
HowUse isoallolithocholic acid to directly inhibit susceptible bacteria
Possible result
Possible independent increase in mean remaining lifespan
From the recordизоаллолитохолевая кислота непосредственно ограничивает чувствительные бактерии

Mechanics and load
Muscle fiber adaptation
The process by which muscle fibers adapt
Where this hypothesis actsMuscle fibers, with other baseline physiological functions preserved
Hypotheses on this target 1
Inhibition
Activation
Function preservation1
Remodelling
Load normalisation
Direct measurement

What is proposed
Function preservation
Support muscle fiber adaptation
With whatNot stated in the record
HowNot stated in the record
Possible result
Possible independent contribution to lifespan extension
From the recordТретий кандидат поддерживает адаптацию мышечных волокон
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Different ways of helping the body maintain itself might each contribute separately to a longer life. The unexpected move is to count feeding the cells lining the colon and suppressing susceptible gut bacteria as two independent routes, even when the same group of microbes supplies both substances. This is a proposal generated by the pipeline, not a measured result: together with muscle adaptation and repair of tissue linings, those routes are proposed to require four distinct interventions.
- The proposed interventions reproduce four bodily functions, with the two gut substances potentially supplied by one group of microbes.
- Butyrate supplies fuel to mature cells lining the colon.
- Isoallolithocholic acid directly suppresses susceptible gut bacteria.
- A third intervention supports adaptation of muscle fibres.
- A fourth intervention supports repair of tissue linings.
- Each function is proposed to increase remaining life independently while the body’s other baseline functions remain intact; removing one leaves a contribution the other three cannot replace.
One delivery van can carry both groceries and cleaning supplies, but delivering them together does not make feeding a household and cleaning it the same job.
Where the picture breaks: Separate jobs do not prove separate survival benefits. In the body, the two substances could depend on each other or feed into a shared response, which is exactly what the competing explanations dispute.
- Master questionstep 01 of 04
New physiological mimetics, interventions that reproduce useful effects of normal bodily processes, might be developed to extend life.
Rests on: The goal is to identify processes worth reproducing and substances, combinations or other interventions that could reproduce their benefits.
Stated in the chain - Goal pillarstep 02 of 04
The intended output is a definite set of new interventions that reproduce normal bodily processes to extend life.
Rests on: The master question explicitly calls for new candidates and explanations of how they might extend life.
Stated in the chain - Gap questionstep 03 of 04
The number of genuinely different interventions would be determined by replacing substances, removing components and changing the order of treatment phases to distinguish interchangeable treatments from separate necessary functions.
Rests on: A definite set requires a rule for deciding when two treatments represent the same function and when they represent different functions.
AssumptionThe stage assumes that suitable established targets and treatment phases are available, and that these replacement and removal comparisons can identify the required functional units. The preceding goal does not specify those targets or establish that rule.
- Hypothesisstep 04 of 04
Four separate interventions are proposed to preserve four independent contributions to longer life. Butyrate, a substance proposed here as fuel for colonocytes, the mature cells lining the colon, supplies one function. Isoallolithocholic acid, a bile acid transformed by microbes, is proposed to supply another by directly suppressing susceptible bacteria. Muscle adaptation and repair of the epithelium, the cell layer covering or lining a tissue, supply the other two.S3S8
Rests on: Two local actions have partial literature support. S3, published in Cell in 2016, reports that mature colon-lining cells can use butyrate as an energy source, but does not establish an independent survival benefit. S8, available here only as an abstract from The Journal of Antibiotics in 2025, reports suppression of methicillin-resistant Staphylococcus aureus, a bacterium resistant to the antibiotic methicillin, by isoallolithocholic acid; its abdominal-cavity infection setting does not establish the proposed action against gut bacteria or longer life. These findings support ingredients of the proposal, not its four-function minimum.
Supported by literature
What is carried, and what is not. Screened sources speak to two of the four proposed local functions: butyrate use by colon-lining cells and an antibacterial action of isoallolithocholic acid, with the latter demonstrated in a different infection setting. None of the supplied sources establishes all four functions as independent causes of longer life, or establishes that four interventions are necessary.
Where the reasoning is carried by something unstated · 1
- Gap question. The stage assumes that suitable established targets and treatment phases are available, and that these replacement and removal comparisons can identify the required functional units. The preceding goal does not specify those targets or establish that rule.
How a result here could mislead · 3
- Replacing susceptible bacteria with resistant bacteria could change survival through altered bacterial growth or chemical activity, making that change look like loss of the proposed antibacterial benefit. What closes it: The specification requires controls for accompanying changes in bacterial growth and chemical activity. Resistance and functional comparability must be verified in the tested setting before a survival difference is attributed to loss of susceptibility.
- Disrupting butyrate use in colon-lining cells could damage their baseline function. A resulting loss of survival benefit could then reflect damage caused by the disruption rather than removal of a distinct beneficial route. What closes it: The comparison must measure whether butyrate use was actually reduced and whether other baseline functions remained intact. Controls with the same disruption but without added butyrate are needed to distinguish the disruption’s own effect from loss of treatment benefit.
- Separating the two gut actions could be mistaken for establishing the full four-intervention minimum. The stated distinguishing prediction focuses on those two actions and does not by itself establish that muscle adaptation and tissue-lining repair provide separate survival benefits. What closes it: The four-function claim requires survival comparisons that independently remove or replace the muscle and tissue-lining interventions as well. Improved cell function or bacterial suppression must be distinguished from the specified outcome, average remaining life.
What would make this wrong. The four-function claim would fail in the tested setting if, with the intended local actions verified and other baseline functions preserved, either gut substance did not independently increase average remaining life. It would also fail if selective disruption did not separate their survival contributions as predicted, or if a smaller set reproduced all four claimed contributions. A failed intervention without verified action on its intended target would not establish those contradictions.
What it would change. If the full hypothesis held, the search for life-extending interventions would have to count distinct causal functions rather than substances or microbial producers: combining production would not merge the benefits into one function. Preserving all four contributions would require representation of each function, although that need not mean four separately delivered products. The narrower predicted separation of the two gut functions would challenge rivals that require those substances to act together, but would not alone settle the four-function count. Even successful animal survival tests would leave human benefit unestablished; the supplied specification gives no particular animal species, treatment amounts or treatment schedule.
Sources read · 8
Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease. · Cells · 2021
“First, they illustrated that rapid uptake and oxidation of butyrate by surface-level colonocytes decreases butyrate levels at the crypt base and produces a butyrate gradient along the crypt axis in mouse colon.”
Does not settle: Источник подтверждает поглощение и окисление бутирата поверхностными колоноцитами у мышей, но не устанавливает продление жизни, самостоятельный причинный вклад этой функции, перенос результата на человека, действие остальных кандидатов или необходимость набора из четырёх представителей.
Butyrate and the Fine-Tuning of Colonic Homeostasis: Implication for Inflammatory Bowel Diseases. · International journal of molecular sciences · 2021
“Butyrate is oxidized to CO 2 by the mitochondrial oxidative phosphorylation system, allowing ATP production. This phenomenon provides 70–80% of energy requirements of healthy colonocytes [ ], regulating the colonic homeostasis.”
Does not settle: Остаются открытыми влияние бутирата на продолжительность жизни, независимость четырёх предполагаемых функций, необходимость четырёх миметиков, роль изоаллолитохолевой кислоты, адаптация мышечных волокон и восстановление эпителия.
The Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites. · 2016
“Taken together, these data suggest that differentiated colonocytes located at the top of crypts can metabolize butyrate as an energy source, thus potentially preventing exposure of the stem cell niche to high levels of luminal butyrate.”
Does not settle: Источник показывает использование бутирата дифференцированными колоноцитами как источника энергии и возможную защиту стволовых клеток крипт. Он не устанавливает продление жизни, самостоятельный причинный вклад этой функции, необходимость четырёх миметиков, действие изоаллолитохолевой кислоты, поддержку мышечной адаптации, восстановление эпителия или преимущества единого микробного консорциума.
Metabolite mimicry identifies butyrate analogs with select protective functions in the intestinal mucosa. · Proceedings of the National Academy of Sciences of the United States of America · 2026
“As shown in , the rate of O 2 consumption was significantly increased by butyrate over vehicle and 3-Cl BA, suggesting that 3-Cl BA is not used as fuel for energy procurement by IEC.”
Does not settle: The source examines intestinal epithelial cell models and a mouse colitis model; it does not establish lifespan extension, independence or additivity of four functions, the proposed four-candidate minimum, muscle adaptation, isoallolithocholic acid-mediated bacterial restriction, or effects in humans.
Novel microbially transformed bile acids: Biosynthesis, structure, and function. · Pharmacological research · 2025
“These novel bile acids had various functions including immunoregulation, receptor regulator, antimicrobial activity, and microbial communities regulating effect.”
Does not settle: The abstract does not establish that isoalloLCA directly inhibits susceptible bacteria, identify those bacteria or effective concentrations, demonstrate lifespan extension, or support the proposed four independent functions and the necessity of four distinct mimetics.
The efficacy of anti-proteolytic peptide R7I in intestinal inflammation, function, microbiota, and metabolites by multi-omics analysis in murine bacterial enteritis. · Bioengineering & translational medicine · 2023
“For the gut microbiota, Clostridia were significantly reduced in the R7I‐treated group, and Odoribacteraceae , an efficient isoalloLCA‐synthesizing strain, was the main dominant strain, protecting the gut from potential pathogens.”
Does not settle: Источник не устанавливает прямое антибактериальное действие изоаллолитохолевой кислоты, её химическую избирательность, влияние бутирата на обмен зрелых колоноцитов, независимость четырёх функций, вклад каждой функции в продолжительность жизни или необходимость набора из четырёх миметиков.
Therapeutic potential of isoallolithocholic acid in methicillin-resistant Staphylococcus Aureus peritoneal infection. · The Journal of antibiotics · 2025
“Our findings demonstrate that isoallo-LCA effectively suppresses the replication of MRSA with minimal adverse effects on mammalian cells.”
Does not settle: The source does not establish lifespan extension, independence or additivity of four physiological functions, the necessity of four distinct representatives, effects in humans, or antibacterial activity beyond MRSA-associated peritoneal infection.
ALSUntangled #64: butyrates. · Amyotrophic lateral sclerosis & frontotemporal degeneration · 2022
“One trial suggests that sodium phenylbutyrate (NaPB) in combination with Tauroursodeoxycholic acid (TUDCA) can slow ALS progression and prolong survival, but the specific contribution of NaPB toward this effect is unclear.”
Does not settle: Источник не устанавливает самостоятельный вклад бутирата в выживаемость, его действие на обмен зрелых колоноцитов, независимость четырёх предполагаемых функций, пользу остальных трёх миметиков или необходимость набора из четырёх представителей. Рассмотрены люди с боковым амиотрофическим склерозом и комбинированное лечение; вклад фенилбутирата натрия остаётся неясным.
The gap this hypothesis explains
Nothing is known here: the question has not been asked of this system.
How many functionally distinct life-extending treatments remain after swapping substances, removing components, or reordering treatment stages?
Original wording · exactly as the pipeline generated it
Сколько функционально самостоятельных миметиков продления жизни образуют воздействия на установленные мишени, если замена веществ, исключение компонентов и перестановка фаз позволяют отделить взаимозаменяемые воздействия от воспроизведения разных необходимых функций?
What this question is asking
The question concerns how many different useful bodily functions a set of life-extending treatments reproduces, rather than how many substances it contains. It asks whether replacing substances, removing parts of a treatment, or changing the order of treatment stages distinguishes interchangeable treatments from treatments that reproduce different necessary functions. The proposed count must remain consistent when equivalent substances are substituted across repeated treatment cycles and survival is followed for the rest of life. This assumes that the treatments act on established biological targets and that these comparisons can identify separate functions; the supplied sources do not establish those assumptions for a specified set of treatments.
- Mimetic
- A substance or other intervention intended to reproduce an effect of a bodily process. In this question, mimetics would be counted by the useful functions they reproduce, rather than simply by their ingredients.
- Functionally independent
- Providing a distinguishable useful contribution that cannot simply be replaced by another contribution in the treatment set. The supplied material does not establish a precise rule for deciding when that condition is met.
- Necessary function
- A contribution required for a specified benefit under specified conditions. A treatment improving survival does not, by itself, establish which of its effects was necessary.
- Biological target
- A part of biological machinery, such as a protein, on which a treatment acts. Identifying a target does not by itself establish a survival benefit or a distinct necessary function.
- Interchangeability
- The ability to replace one treatment component with another while preserving the relevant function and outcome. Here, that equivalence is required to persist across repeated treatment and remaining-life follow-up.
- Component removal
- Leaving an ingredient or other element out of a combined treatment. The question asks whether the resulting change can distinguish redundant contributions from necessary ones.
- Treatment stage or phase
- One scheduled part of a treatment sequence. Reordering phases changes when components act relative to one another, even if the components themselves remain the same.
- Treatment cycle
- One complete repetition of a treatment schedule. The requested count must remain meaningful after multiple repetitions.
- Lifespan and remaining-life follow-up
- Lifespan is the length of an organism's life. Remaining-life follow-up means observing survival from the relevant starting point until death, rather than relying only on an earlier measurement.
- Additive effect
- A combined effect described as adding the contributions of the treatments on the study's measurement scale. S2 uses this description, but the supplied quotation does not give the scale, effect sizes, or a demonstration of separate necessary functions.
- Trametinib
- One of the drugs studied in S2. The supplied quotation reports lifespan extension in male and female mice but does not describe its biological target.
- Rapamycin
- The second drug in the combination reported by S2. The supplied quotation describes the combination as additive but does not specify rapamycin's separate effect size or mechanism.
- Protein assembly
- A group of proteins working together within a cell. S8 reports that the assemblies it discusses have distinct cellular functions, without establishing that these correspond to distinct life-extending mimetics.
- Genetic change
- An alteration to an organism's inherited biological instructions. S1 mentions such changes as one way aging is studied, without reporting how they resolve the functional-count question.
The interventions act on established targets, and substance substitution, component removal, and phase reordering can distinguish interchangeable interventions from reproduction of different necessary functions.
The assumption concerns substances or other treatments acting on identified parts of the body's machinery. It assumes that exchanging ingredients, leaving ingredients out, and changing when they are given can reveal whether treatments do the same useful job or different necessary jobs. If that distinction holds through repeated use and lifelong follow-up, it would provide a basis for counting treatments by function.
The supplied sources do not identify the complete treatment set or establish this counting rule. S2 reports an additive survival benefit from combining two drugs, but the supplied account does not establish interchangeability, necessary functions, or stability under repeated substitutions and schedule changes. S8 describes protein assemblies with distinct cellular functions, which does not establish distinct life-extending treatments. No supplied source establishes the premise; this limitation does not show that the premise is false.S2S8
The same question asked without the part nothing read establishes:
- For a specified set of life-extending treatments, what evidence distinguishes interchangeable ingredients from ingredients contributing different functions?
- Do changes in treatment ingredients or their order preserve the survival benefit across repeated treatment cycles and the remaining lifespan?
- One shared function If the treatments reproduce the same useful function and substitutions preserve the survival benefit, different ingredients would represent alternative ways of supplying that function. Counting each ingredient or formulation as a separate functional treatment would overcount.
- Several distinct necessary functions If different treatment components provide different necessary functions, replacing one component with something that supplies another function would leave a contribution missing. A count based only on interchangeable ingredients would then fail to capture the separate functions required for the benefit.
- The count depends on timing or repeated use If an ingredient's contribution changes with treatment order or repeated cycles, equivalence under one schedule would not establish equivalence under another. The result would be a count tied to particular treatment conditions, rather than the stable count requested.
A treatment's ingredients, the biological processes it changes, and its effect on survival are different things. If two ingredients reproduce the same useful function, counting ingredients separately could overstate the number of distinct treatments. If different ingredients provide different necessary functions, treating them as interchangeable could remove a contribution needed for the survival benefit. If their order matters, changing the schedule could change the benefit even when the ingredients stay the same. The question therefore turns on whether differences in composition or timing correspond to differences in function that persist over the remaining lifespan.
S-узлы уровней RL-1 и RL-2 описывают заменяемые компоненты и зависимость от режима, но не устанавливают число самостоятельных миметиков.
Число самостоятельных миметиков устойчиво к замене эквивалентных компонентов на протяжении повторных циклов и наблюдения оставшейся жизни.
Неизвестно, сколько разных причинных функций реализует набор воздействий и когда изменение состава или последовательности создаёт самостоятельный миметик.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Предлагаемый минимальный набор содержит четыре самостоятельных миметика: B, L, C и E. Дополнительное разделение микробного кандидата основано на химической избирательности двух физиологических функций. Бутират поддерживает обмен зрелых колоноцитов; изоаллолитохолевая кислота непосредственно ограничивает чувствительные бактерии. Каждая функция, согласно гипотезе, даёт собственный выигрыш жизни при сохранности остальных исходных функций организма. Их совместное получение одним консорциумом объединяет производство, но сохраняет два самостоятельных действия. Третий кандидат поддерживает адаптацию мышечных волокон, четвёртый обеспечивает восстановление эпителия. Четыре представителя необходимы для сохранения всех четырёх причинных вкладов; набор из трёх утрачивает один из них.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
B и L по отдельности увеличивают среднюю оставшуюся жизнь относительно контроля и сохраняют разные причинные зависимости. При замене чувствительных кишечных бактерий на функционально сопоставимые устойчивые варианты исчезает вклад L, тогда как вклад B сохраняется. При избирательном нарушении использования бутирата зрелыми колоноцитами исчезает вклад B, тогда как антимикробное действие и выигрыш от L сохраняются. Ни C, ни E не восстанавливают эти утраченные функции. Такая двойная диссоциация отвергает ответы с единым микробным кандидатом.
Would tell it apart from at least one rival. The prediction specifies lifespan increases relative to control, selective loss and preservation of effects under stated interventions, failure to restore lost functions, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Раздельную причинность можно сначала проверить в культурах колоноцитов и бактериальных культурах, затем в животных с заданной микробиотой. Изменение бактериальной устойчивости требует контроля сопутствующих изменений роста и обмена. Самостоятельное продление жизни каждым метаболитом остаётся проверяемой гипотезой.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
B и L по отдельности увеличивают среднюю оставшуюся жизнь относительно контроля и сохраняют разные причинные зависимости. При замене чувствительных кишечных бактерий на функционально сопоставимые устойчивые варианты исчезает вклад L, тогда как вклад B сохраняется. При избирательном нарушении использования бутирата зрелыми колоноцитами исчезает вклад B, тогда как антимикробное действие и выигрыш от L сохраняются. Ни C, ни E не восстанавливают эти утраченные функции. Такая двойная диссоциация отвергает ответы с единым микробным кандидатом.
- Rival 01 of 03What would separate them
One shared recovery pattern of kinase activity may extend life by completing tissue repair predicts: Избирательное нарушение восстановительной динамики ERK в названных клетках устраняет выигрыш жизни от каждого из четырёх воздействий при сохранении их ближайших эффектов, включая образование метаболитов и мышечные сокращения. Прямое воспроизведение траектории ERK восстанавливает тканевую функцию и выигрыш жизни после исключения любого из четырёх воздействий. Сохранение хотя бы одного самостоятельного выигрыша жизни при таком нарушении отвергает ответ «один» в пользу многокомпонентных ответов.
- Rival 02 of 03What would separate them
Gut chemical defence and tissue recovery may extend life through two distinct functions predicts: После подтверждённого выпадения ответа на C воздействие E полностью восстанавливает заранее заданный профиль тканевого восстановления и соответствующий вклад в оставшуюся жизнь; обратная замена также успешна. Одновременное выпадение C и E устраняет этот вклад. Воздействия C или E не заменяют B+L. Исключение B либо L устраняет собственный выигрыш жизни микробного кандидата. Таким образом, две реализации C и E повышают надёжность одного миметика, сохраняя число самостоятельных кандидатов равным двум.
- What would separate them
Distinct signal decoders may separate muscle and epithelial longevity mimetics predicts: При сохранении суммарного воздействия изменение временного рисунка C избирательно устраняет мышечную адаптацию и её вклад в продолжительность жизни; E этот вклад не восстанавливает. Перестановка фаз E избирательно нарушает восстановление эпителия при сохранном ответе C. Возврат соответствующей последовательности восстанавливает только утраченную функцию. Одновременно B и L по отдельности сохраняют ближайшие эффекты, но выигрыш жизни даёт лишь их сочетание. Получается ровно три самостоятельных кандидата в ограниченном наборе.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.